Brånemark Novum: a new treatment concept for rehabilitation of the edentulous mandible. Preliminary results from a prospective clinical follow-up study.

BACKGROUND: Brånemark fixtures were originally prescribed to be placed in two surgical stages. During the past years, reports on the placement of machined titanium implants in a one-stage procedure have been published, and the results have been encouraging. Recently there has been considerable interest in early or immediate loading. PURPOSE: The purpose of this article is to report the preliminary clinical results of a new method for implant treatment of the edentulous mandible. The new protocol involves prefabricated components and surgical guides, elimination of the prosthetic impression procedure and attachment of the permanent fixed bridge on the day of implant placement. METHODS: Fifty patients (26 males, 24 females) received 150 Brånemark Novum implants and were followed from 6 months to 3 years after implant placement. Bone width and height were determined preoperatively with the use of radiographs. The jaw was reduced in height to accommodate three special 5-mm wide implants. Precise implant positioning was accomplished with special drilling templates. Drill guides were placed over the drilling templates during site preparation using a series of specially designed drills. After the mucosa had been sutured back into position, a prefabricated titanium lower bar was connected with titanium screws to the transmucosal fixture. Another titanium bar was then attached by the prosthodontist, and a bite registration was performed. The bridge was attached to the upper bar. The permanent reconstruction was provided to the patient later the same day. RESULTS: Three implants were lost to follow-up and three failed, resulting in an overall survival rate of 98%. One prosthesis failed, leaving a prosthetic survival rate of 98%. The average treatment time was approximately 7 hours. At the baseline examination, the marginal bone level was 0.72 mm below the reference point. The average marginal bone loss was 0.2 mm per year and 0.26 mm between the 3-month and 1-year control visits. The accumulated mean bone loss, including baseline, was -1.25 mm. A patient questionnaire demonstrated that 94% of the patients did not experience any discomfort during treatment and all patients would recommend the procedure to others. CONCLUSION: The results of this study indicate that the precise surgical and prosthetic protocol allows successful prosthetic rehabilitation of mandibular edentulism and that the permanent reconstruction can be provided to the patient on the day of fixture surgery.

Brånemark Novum: prosthodontic and dental laboratory procedures for fabrication of a fixed prosthesis on the day of surgery.

PURPOSE: The purpose of this report is to describe a new technique to fabricate and deliver an implant-supported fixed prosthesis to the patient on the day of surgery, and to propose a protocol for the prosthodontic and dental laboratory procedures. MATERIALS AND METHODS: The development of the Brånemark Novum prosthodontic protocol is reviewed, and clinical and dental laboratory assessments and methods are described. RESULTS: The total treatment time to fabricate a permanent implant-supported fixed prosthesis in the mandible can be reduced to 1 day with the Brånemark Novum technique. The new method includes a precise surgical technique using drilling templates for predetermined implant positions, a rigid splinting of the implants immediately after placement, the use of a prefabricated titanium framework, and elimination of implant impression procedures. CONCLUSION: With the technique described in this report, it is possible to provide patients with a permanent implant-supported fixed prosthesis in the mandible on the day of implant surgery. Patient benefits are obvious, with drastically reduced total treatment time, lower cost, and fewer clinical visits.

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey.

Breakthrough pain (BKP) is a transitory flare of pain that occurs on a background of relatively well controlled baseline pain. Previous surveys have found that BKP is highly prevalent among patients with cancer pain and predicts more severe pain, pain-related distress and functional impairment, and relatively poor quality of life. An international group of investigators assembled by a task force of the International Association for the Study of Pain (IASP) evaluated the prevalence and characteristics of BKP as part of a prospective, cross-sectional survey of cancer pain. Fifty-eight clinicians in 24 countries evaluated a total of 1095 patients with cancer pain using patient-rated items from the Brief Pain Inventory (BPI) and observer-rated measures. The observer-rated information included demographic and tumor-related data, the occurrence of BKP, and responses on checklists of pain syndromes and pathophysiologies. The clinicians reported BKP in 64.8% of patients. Physicians from English-speaking countries were significantly more likely to report BKP than other physicians. BKP was associated with higher pain scores and functional interference on the BPI. Multivariate analysis showed an independent association of BKP with the presence of more than one pain, a vertebral pain syndrome, pain due to plexopathy, and English-speaking country. These data confirm the high prevalence of BKP, its association with more severe pain and functional impairment, and its relationship to specific cancer pain syndromes. Further studies are needed to characterize subtypes of BKP. The uneven distribution of BKP reporting across pain specialists from different countries suggests that more standardized methods for diagnosing BKP are needed.